Pond S M, Birkett D J, Wade D N
Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):573-9. doi: 10.1002/cpt1977225part1573.
Tolbutamide half-life was increased by chronic administration of sulfaphenazole (9.5 hr to 28.6 hr, n = 2), phenylbutazone (7.9 hr to 23.1 hr, n = 8), and oxyphenbutazone (8.1 hr to 30.2 hr, n = 2). The rate of elimination of tolbutamide was decreased within 1 to 2 hr of a single dose of sulfaphenazole and the tolbutamide half-life was increased from 9.2 hr to 25.7 hr (n = 2). In contrast, phenylbutazone and oxyphenbutazone, administered as single oral doses of 800 mg, had no immediate effect on tolbutamide elimination. At times greater than 20 to 30 hr after the single dose of phenylbutazone or oxyphenbutazone the rate of tolbutamide elimination was decreased. It is suggested that phenylbutazone and oxyphenbutazone act by inducing form of cytochrome P-450 with low activity for tolbutamide hydroxylation, whereas sulfaphenazole acts by direct inhibition of the microsomal mixed function oxidase system.
慢性给予磺胺苯吡唑(半衰期从9.5小时增至28.6小时,n = 2)、保泰松(半衰期从7.9小时增至23.1小时,n = 8)和羟布宗(半衰期从8.1小时增至30.2小时,n = 2)可使甲苯磺丁脲的半衰期延长。单次给予磺胺苯吡唑后1至2小时内,甲苯磺丁脲的消除速率降低,其半衰期从9.2小时增至25.7小时(n = 2)。相比之下,单次口服800 mg保泰松和羟布宗对甲苯磺丁脲的消除无即刻影响。单次给予保泰松或羟布宗20至30小时后,甲苯磺丁脲的消除速率降低。提示保泰松和羟布宗通过诱导对甲苯磺丁脲羟化活性低的细胞色素P-450发挥作用,而磺胺苯吡唑通过直接抑制微粒体混合功能氧化酶系统发挥作用。